Author

E. T. Liu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:deep learning· 1 Research Focus:gene regulatory network inference· 1 Assay:long-read sequencing· 1

Frequent Co-Authors

A. K. Simons· 1 shared A. S. Zhu· 1 shared A. Srivastava· 1 shared B. J. Sanderson· 1 shared C. G. Tepper· 1 shared C. H. Wong· 1 shared C. J. Bult· 1 shared C. Kuhlberg· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Simons

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivMar 6, 2022

A Genomically and Clinically Annotated Patient Derived Xenograft (PDX) Resource for Preclinical Research in Non-Small Cell Lung Cancer

X. Y. Woo, A. Srivastava, P. C. Mack…·C. J. Bult

The paper describes a collection of 79 genomically and clinically annotated lung cancer PDX models that retain patient tumor features and treatment responses, available through MMHCdb.

DOI 10.1158/0008-5472.can-22-0948

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 19, 2021

Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas

F. Menghi, K. Banda, P. Kumar…·E. T. Liu

This study identifies that BRCA1 promoter methylation (BRCA1meth) leads to adaptive recovery of BRCA1 expression and poorer response to platinum chemotherapy compared to BRCA mutations, while immune signals enhance response in BRCA-proficient cancers.

DOI 10.1101/2021.08.19.456799

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologybioRxivPreprintFeb 6, 2021

Subgenomic RNAs as molecular indicators of asymptomatic SARS-CoV-2 infection

C. H. Wong, C. Y. Ngan, R. L. Goldfeder…·C.-L. Wei

The paper examines subgenomic RNA (sgRNA) expression and structural variations in symptomatic and asymptomatic SARS-CoV-2 infections to correlate with disease severity.

DOI 10.1101/2021.02.06.430041

humanlong-read sequencing

𝕏 PostBluesky